Evidence map›Paper›PMID 27183631›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes.

Alexandra Bettina, Zhimin Zhang, Kathryn Michels, R Elaine Cagnina, Isaah S Vincent, Marie D Burdick, Alexandra Kadl, Borna Mehrad

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Emerging roles of IL-34 in health and disease.The Journal of experimental medicine · 2020
    Review
  10. mBio · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexandra BettinaDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908;
Zhimin ZhangDivision of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA 22908;
Kathryn MichelsDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908;
R Elaine CagninaDivision of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA 22908;
Isaah S VincentDivision of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA 22908;
Marie D BurdickDivision of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA 22908;
Alexandra KadlDivision of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA 22908; Department of Pharmacology, University of Virginia, Charlottesville, VA 22908; and.ORCID 0000-0001-6285-574X
Borna MehradDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908; Division of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA 22908; Beirne B. Carter Center for Immunology, University of Virginia, Charlottesville, VA 22908 mehrad@virginia.edu.
University of Virginia · USCarter Center · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Fibrocytes in human pulmonary fibrosisR01HL098329 · NHLBI · UNIVERSITY OF VIRGINIA · PI MEHRAD, BORNA, ROSE, C EDWARD · 2011 to 2015
$2.7M
The Role of Apoptotic Cell Clearance in Acute Lung InjuryK08HL121187 · NHLBI · UNIVERSITY OF VIRGINIA · PI KADL, ALEXANDRA · 2014 to 2018
$754k
Neutrophils and adaptive immunity against invasive aspergillosisR21AI117397 · NIAID · UNIVERSITY OF VIRGINIA · PI MEHRAD, BORNA · 2015 to 2016
$435k
NHLBI NIH HHS K08 HL121187NHLBI NIH HHS R01 HL098329NIAID NIH HHS R21 AI117397NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

Gram-negative bacterial pneumonia is a common and dangerous infection with diminishing treatment options due to increasing antibiotic resistance among causal pathogens. The mononuclear phagocyte system is a heterogeneous group of leukocytes composed of tissue-resident macrophages, dendritic cells, and monocyte-derived cells that are critical in defense against pneumonia, but mechanisms that regulate their maintenance and function during infection are poorly defined. M-CSF has myriad effects on mononuclear phagocytes but its role in pneumonia is unknown. We therefore tested the hypothesis that M-CSF is required for mononuclear phagocyte-mediated host defenses during bacterial pneumonia in a murine model of infection. Genetic deletion or immunoneutralization of M-CSF resulted in reduced survival, increased bacterial burden, and greater lung injury. M-CSF was necessary for the expansion of lung mononuclear phagocytes during infection but did not affect the number of bone marrow or blood monocytes, proliferation of precursors, or recruitment of leukocytes to the lungs. In contrast, M-CSF was essential to survival and antimicrobial functions of both lung and liver mononuclear phagocytes during pneumonia, and its absence resulted in bacterial dissemination to the liver and hepatic necrosis. We conclude that M-CSF is critical to host defenses against bacterial pneumonia by mediating survival and antimicrobial functions of mononuclear phagocytes in the lungs and liver.

Indexed as

AnimalsAntibodies, NeutralizingBone MarrowBone Marrow CellsKlebsiella InfectionsKlebsiella pneumoniaeLiverLungMacrophage Colony-Stimulating FactorMiceMonocytesMononuclear Phagocyte SystemPhagocytesPneumonia, BacterialAntibodies, NeutralizingMacrophage Colony-Stimulating Factor

Identifiers

PMID27183631
PMCPMC4893984
OpenAlexW2345388526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.